Sensitive determination of prulifloxacin by its fluorescence enhancement on terbium(III)-sodium dodecylbenzene sulfonate system

Analytical Letters

Volumn 41, Issue 17, 2008, Pages 3124-3137

  Yu, Fengshan ^a,b   Zhou, Dazhai ^a   Wu, Kangbing ^a   Chen, Fang ^a,b  

^a HUBEI UNIVERSITY FOR NATIONALITIES   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Prulifloxacin; Spectrofluorimetry; Terbium

Indexed keywords

EID: 57649140594     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710802463121     Document Type: Article

References (16)

1. Feng, Y.F., Li, K.X., lv, Y.F., Xie, F., Sun, C.H., and Zhou, Z.M. 2006. Determination of prulitloxacin and its related substances in capsules by HPLC. Chin. Pharm. J., 41: 308-309.
2. Guo, L.X., Qi, M.L., Jin, X., Wang, P., and Zhao, H.Q. 2006. Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B, 832: 280-285.
3. Han, Y.X., Wu, X., Yang, J.H., and Sun, S.N. 2005. The fluorescence characteristic of the yttrium-norfloxacin system and its analytical application. J. Pharm. Biomed. Anal., 38: 528-531.
4. Keam, S.J. and Perry, C.M. 2004. Prulifloxacin. Drugs, 64: 2221-2234.
5. Luo, A.T., Liu, H.F., Wang, X.K., and Li, H. 2006. Determination of residual organic solvents in prulixacin by headspace capillary gas chromatography. Memoir., 3: 31-33.
6. Nakashima, M., Uematsu, T., Kosuge, K., Okuhama, Y., Morino, A., Ozaki, M., and Takebe, Y. 1994. Pharmacokinetics and safety of NM441, a new quinolone in health male volunteers. J. Clin. Pharmacol., 34: 930-937.
7. Ocana, J.A., Barragan, F.J., and Callejon, M. 2004. Fluorescence and terbium sensitized luminescence determination of garenoxacin in human urine and serum. Talanta, 63: 691-697.
8. Ocana, J.A., M. Callejon, and Barragan, F.J. 2001. Determination of trovafloxacin in human serum by time resolved terbium-sensitised luminescence. Eur. J. Pharmaceut. Sci., 13: 297-301.
9. Okuhama, Y., Momota, K., and Morino, A. 1997. Pharmacokinetics of prulifloxacin first communication: Absorption, distribution, and excretion in rats, dogs and monkeys after a single administration. Arzneim-Forsch, 47: 276-284.
10. Picollo, R., Brion, N., Gualano, V., Millerioux, L., Marchetti, M., Rosignoli, M.T., and Dionisio, P. 2003. Pharmacokinetics and tolerability of prulifloxacin after single oral administration. Arzneim-Forsch., 53: 201-205.
11. Shah, S.S., Naeem, K., Shah, S.W.H., and Laghari, G.M. 2000. Differential absorbance measurements of amphiphilic hemicyanine dyes, solubilization study in anionic surfactant. Colloids Surf. A, 168: 77-85.
12. Tong, C. and Xiang, G. 2007. Sensitive determination of enoxacin by its enhancement effect on the fluorescence of terbium(III)-sodium dodecylbenzene sulphonate and its luminescence mechanism. Luminescence, 126: 575-580.
13. Tong, C.L., Xiang, G.H., Huang, D.J., and Liu, W.P. 2004. Determination of ofloxacin by the terbium(III) ion fluorescence probe sensitized by the surfactant. Chin. J. Anal. Chem., 32: 619-621.
14. Tong, C.L., Zhu, Y., and Liu, W.P. 2001. Study on the co-luminescence system of Dy-Gd-1,6-bis(1′-phenyl-3′-methyl-5′-pyrazol- 4′-one)hexanedionecetyltrimethyl lammonium bromide and its analytical application. Analyst 126: 1168-1171.
15. Tougou, K., Nakamura, A., Watanabe, S., Okuyama, Y., and Morino, A. 1998. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drugs Metab. Dispos. 26: 355-359.
16. Yu, F.S., Li, L., and Chen, F. 2008. Determination of adenosine disodium triphosphate using prulifloxacin-terbium(III) as a fluorescence probe by spectrofluorimetry. Anal. Chim. Acta., 610: 257-262.